AARD
Aardvark Therapeutics, Inc.
Company overview
- Market capitalization
- $115.33M
- Employees
- 40
- Latest publication
- 2026-09-29
About Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 11,000USD | 10,000USD | 10,000USD | — | 5,000USD | — | 87,000USD | 48,000USD |
| Gross Profit | -11,000USD | -10,000USD | -10,000USD | — | -5,000USD | — | -87,000USD | -48,000USD |
| Research Development | 16,567,000USD | 14,299,000USD | 13,737,000USD | 13,145,000USD | 7,755,000USD | 8,062,000USD | 4,065,000USD | 4,029,000USD |
| Selling General Administrative | 5,897,000USD | 4,405,000USD | 3,966,000USD | 2,703,000USD | 2,715,000USD | 1,388,000USD | 1,026,000USD | 2,030,000USD |
| Total Operating Expenses | 22,464,000USD | 18,704,000USD | 17,703,000USD | 15,848,000USD | 10,470,000USD | 9,450,000USD | 5,091,000USD | 6,073,000USD |
| Operating Income | -22,464,000USD | -18,704,000USD | -17,703,000USD | -15,848,000USD | -10,470,000USD | -9,450,000USD | -5,091,000USD | -6,073,000USD |
| Interest Income | 889,000USD | 1,125,000USD | 1,351,000USD | 1,488,000USD | 1,175,000USD | 717,000USD | 1,000,000USD | 594,000USD |
| Net Interest Income | 889,000USD | 1,125,000USD | 1,351,000USD | 1,488,000USD | 1,175,000USD | 717,000USD | 1,000,000USD | 594,000USD |
| Income Before Tax | -21,588,000USD | -17,598,000USD | -16,316,000USD | -14,367,000USD | -9,310,000USD | -8,779,000USD | -4,182,000USD | -5,449,000USD |
| Net Income | -21,588,000USD | -17,598,000USD | -16,316,000USD | -14,367,000USD | -9,310,000USD | -8,779,000USD | -4,182,000USD | -5,449,000USD |
| Net Income From Continuing Ops | -21,588,000USD | -17,598,000USD | -16,316,000USD | -14,367,000USD | -9,310,000USD | -8,779,000USD | -4,182,000USD | -5,449,000USD |
| Ebit | -22,475,000USD | -18,704,000USD | -17,703,000USD | -15,848,000USD | -10,470,000USD | -9,450,000USD | -5,091,000USD | -6,057,000USD |
| Ebitda | -22,464,000USD | -18,694,000USD | -17,693,000USD | -15,837,000USD | -10,465,000USD | -9,450,000USD | -5,083,000USD | -6,059,000USD |
| Depreciation And Amortization | 11,000USD | 10,000USD | 10,000USD | 11,000USD | 5,000USD | 8,000USD | 8,000USD | -2,000USD |
| Reconciled Depreciation | 11,000USD | 10,000USD | 10,000USD | 11,000USD | 5,000USD | -121,000USD | 87,000USD | -2,000USD |
| Total Other Income Expense Net | 876,000USD | 1,106,000USD | 1,387,000USD | 1,481,000USD | 1,160,000USD | 671,000USD | 909,000USD | 624,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 14,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 36,000USD | 16,000USD | 97,000USD | 110,000USD |
| Gross Profit | -36,000USD | -16,000USD | -97,000USD | -110,000USD |
| Research Development | 48,936,000USD | 17,363,000USD | 4,480,000USD | 7,172,000USD |
| Selling General Administrative | 13,789,000USD | 5,305,000USD | 2,173,000USD | 2,702,000USD |
| Total Operating Expenses | 62,725,000USD | 22,785,000USD | 7,415,000USD | 11,363,000USD |
| Operating Income | -62,725,000USD | -22,785,000USD | -7,415,000USD | -11,363,000USD |
| Interest Income | 5,139,000USD | 2,414,000USD | 1,423,000USD | 120,000USD |
| Net Interest Income | 5,139,000USD | 2,414,000USD | 1,423,000USD | 120,000USD |
| Income Before Tax | -57,591,000USD | -20,588,000USD | -7,208,000USD | -13,564,000USD |
| Net Income | -57,591,000USD | -20,588,000USD | -7,208,000USD | -13,564,000USD |
| Net Income From Continuing Ops | -57,591,000USD | -20,588,000USD | -7,208,000USD | -13,564,000USD |
| Ebit | -62,725,000USD | -22,668,000USD | -7,415,000USD | -10,874,000USD |
| Ebitda | -62,689,000USD | -22,652,000USD | -6,653,000USD | -10,764,000USD |
| Depreciation And Amortization | 36,000USD | 16,000USD | 97,000USD | 110,000USD |
| Reconciled Depreciation | 36,000USD | 16,000USD | 97,000USD | 110,000USD |
| Total Other Income Expense Net | 5,134,000USD | 2,197,000USD | 207,000USD | -2,201,000USD |
| Unclassified Operating Expenses | — | — | — | 1,489,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 81,460,000USD | 98,590,000USD | 117,181,000USD | 133,229,000USD | 147,475,000USD | 157,025,000USD | 77,507,000USD | 83,739,000USD |
| Cash And Equivalents | 73,849,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 73,870,000USD | 91,200,000USD | 110,027,000USD | 126,350,000USD | 141,820,000USD | 151,260,000USD | 73,663,000USD | 82,360,000USD |
| Short Term Investments | 21,000USD | 28,764,000USD | 62,976,000USD | 87,065,000USD | 115,822,000USD | 124,756,000USD | 12,022,000USD | 83,000USD |
| Total Current Assets | 80,661,000USD | 93,580,000USD | 111,886,000USD | 129,207,000USD | 144,768,000USD | 154,554,000USD | 74,137,000USD | 82,666,000USD |
| Other Current Assets | 6,791,000USD | 2,380,000USD | 1,859,000USD | 2,857,000USD | 2,948,000USD | 3,294,000USD | 474,000USD | 306,000USD |
| Other Non Current Assets | 173,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 6,663,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 6,387,000USD | 11,604,000USD | 10,548,000USD | 10,736,000USD | 10,310,000USD | 5,976,000USD | 4,927,000USD | 2,612,000USD |
| Other Current Liabilities | 3,900,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 74,797,000USD | 86,986,000USD | 106,633,000USD | 122,377,000USD | 136,925,000USD | 150,689,000USD | -54,643,000USD | -46,174,000USD |
| Total Equity Including Noncontrolling Interest | 74,797,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 626,000USD | 269,000USD | 355,000USD | 439,000USD | 522,000USD | 628,000USD | 735,000USD | 841,000USD |
| Accounts Payable | 2,086,000USD | 4,493,000USD | 2,072,000USD | 4,444,000USD | 5,056,000USD | 2,556,000USD | 2,298,000USD | 666,000USD |
| Short Term Debt | 401,000USD | 336,000USD | 441,000USD | 429,000USD | 417,000USD | 390,000USD | 338,000USD | 323,000USD |
| Common Stock | 0USD | — | — | — | — | — | — | — |
| Retained Earnings | -151,893,000USD | -137,506,000USD | -115,918,000USD | -98,320,000USD | -82,004,000USD | -67,637,000USD | -58,327,000USD | -49,548,000USD |
| Accumulated Other Comprehensive Income | 0USD | 14,000USD | 81,000USD | 82,000USD | -3,000USD | 44,000USD | — | — |
| Total Liab | — | 11,604,000USD | 10,548,000USD | 10,852,000USD | 10,550,000USD | 6,336,000USD | 132,150,000USD | 129,913,000USD |
| Other Current Liab | — | 6,775,000USD | 8,035,000USD | 5,863,000USD | 4,837,000USD | 3,030,000USD | 2,291,000USD | 1,623,000USD |
| Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cash | — | 62,436,000USD | 47,051,000USD | 39,285,000USD | 25,998,000USD | 26,504,000USD | 61,641,000USD | 82,277,000USD |
| Net Debt | — | -62,100,000USD | -46,610,000USD | -38,740,000USD | -25,353,000USD | -25,778,000USD | -60,862,000USD | -81,409,000USD |
| Short Long Term Debt Total | — | 336,000USD | 441,000USD | 545,000USD | 645,000USD | 726,000USD | 779,000USD | 868,000USD |
| Property Plant Equipment Gross | — | 269,000USD | 355,000USD | 439,000USD | 522,000USD | 628,000USD | 735,000USD | 841,000USD |
| Common Stock Shares Outstanding | — | 21,815,995shares | 21,815,353shares | 21,745,265shares | 21,693,016shares | 21,688,172shares | 21,695,920shares | 21,384,377shares |
| Non Current Assets Total | — | 5,010,000USD | 5,295,000USD | 4,022,000USD | 2,707,000USD | 2,471,000USD | 3,370,000USD | 1,073,000USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 116,000USD | 240,000USD | 360,000USD | 127,223,000USD | 127,301,000USD |
| Non Currrent Assets Other | — | 4,741,000USD | 4,940,000USD | 3,583,000USD | 2,185,000USD | 1,843,000USD | 2,635,000USD | 232,000USD |
| Net Working Capital | — | 81,976,000USD | 101,338,000USD | 118,471,000USD | 134,458,000USD | 148,578,000USD | 69,210,000USD | 80,054,000USD |
| Unclassified Equity | — | 224,478,000USD | 222,470,000USD | 220,615,000USD | 218,932,000USD | 218,282,000USD | 3,684,000USD | 3,374,000USD |
| Non Current Liabilities Other | — | — | — | — | 12,000USD | 24,000USD | 26,000USD | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | 127,197,000USD | 127,301,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Assets | 117,181,000USD | 77,507,000USD | 10,536,000USD | 16,757,000USD |
| Other Current Assets | 1,859,000USD | 474,000USD | 379,000USD | 386,000USD |
| Total Liab | 10,548,000USD | 132,150,000USD | 45,338,000USD | 44,680,000USD |
| Total Stockholder Equity | 106,633,000USD | -54,643,000USD | -34,802,000USD | -27,923,000USD |
| Other Current Liab | 8,035,000USD | 2,291,000USD | 235,000USD | 236,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -115,918,000USD | -58,327,000USD | -37,739,000USD | -30,531,000USD |
| Cash | 47,051,000USD | 61,641,000USD | 9,735,000USD | 15,559,000USD |
| Cash And Short Term Investments | 110,027,000USD | 73,663,000USD | 9,989,000USD | 16,105,000USD |
| Total Current Assets | 111,886,000USD | 74,137,000USD | 10,368,000USD | 16,491,000USD |
| Total Current Liabilities | 10,548,000USD | 4,927,000USD | 1,382,000USD | 595,000USD |
| Net Debt | -46,610,000USD | -60,862,000USD | -9,573,000USD | -15,297,000USD |
| Short Term Debt | 441,000USD | 338,000USD | 112,000USD | 100,000USD |
| Short Long Term Debt Total | 441,000USD | 779,000USD | 162,000USD | 262,000USD |
| Short Term Investments | 62,976,000USD | 12,022,000USD | 254,000USD | 546,000USD |
| Accounts Payable | 2,072,000USD | 2,298,000USD | 1,035,000USD | 259,000USD |
| Property Plant Equipment Net | 355,000USD | 735,000USD | 155,000USD | 252,000USD |
| Property Plant Equipment Gross | 355,000USD | 735,000USD | 155,000USD | 252,000USD |
| Accumulated Other Comprehensive Income | 81,000USD | — | — | — |
| Common Stock Shares Outstanding | 21,815,353shares | 21,695,920shares | 21,384,377shares | 21,384,377shares |
| Non Current Assets Total | 5,295,000USD | 3,370,000USD | 168,000USD | 266,000USD |
| Non Current Liabilities Total | 0USD | 127,223,000USD | 43,956,000USD | 44,085,000USD |
| Non Currrent Assets Other | 4,940,000USD | 2,635,000USD | 13,000USD | 14,000USD |
| Net Working Capital | 101,338,000USD | 69,210,000USD | 8,986,000USD | 15,896,000USD |
| Unclassified Equity | 222,470,000USD | 3,684,000USD | 2,937,000USD | 2,608,000USD |
| Non Current Liabilities Other | — | 26,000USD | 2,000USD | 19,000USD |
| Unclassified Non Current Liabilities | — | 127,197,000USD | 43,954,000USD | 44,066,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 22,000USD |
| Stock Based Compensation | 3,954,000USD |
| Change To Liabilities | -4,121,000USD |
| Change In Working Capital | -173,000USD |
| Operating Cash Flow | -36,468,000USD |
| Capital Expenditures | 0USD |
| Unclassified Investing Cash Flow | 63,000,000USD |
| Investing Cash Flow | 63,000,000USD |
| Financing Cash Flow | 266,000USD |
| Change In Cash | 26,798,000USD |
| End Cash Flow | 73,849,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -21,588,000USD | -17,598,000USD | -16,315,999USD | -14,367,000USD | -9,310,000USD | -8,779,000USD | -4,182,000USD | -5,449,000USD |
| Depreciation | -118,000USD | 10,000USD | 10,000USD | -620,000USD | 5,000USD | -121,000USD | 87,000USD | 48,000USD |
| Stock Based Compensation | 2,004,000USD | 1,581,000USD | 1,500,000USD | 634,000USD | 233,000USD | 173,000USD | 145,000USD | 54,000USD |
| Other Non Cash Items | 110,000USD | 3,838,000USD | -1,212,000USD | 124,000USD | 41,000USD | 185,000USD | 91,000USD | -41,000USD |
| Change In Working Capital | 723,000USD | -673,000USD | -999,000USD | 4,385,000USD | -2,357,000USD | 815,000USD | -96,000USD | 1,173,000USD |
| Total Cash From Operating Activities | -18,869,000USD | -14,423,000USD | -18,517,000USD | -9,844,000USD | -11,388,000USD | -7,727,000USD | -3,955,000USD | -4,215,000USD |
| Capital Expenditures | 0USD | 0USD | -4,000USD | -91,000USD | 0USD | -6,000USD | -5,000USD | -93,000USD |
| Free Cash Flow | -18,869,000USD | -14,423,000USD | -18,521,000USD | -9,935,000USD | -11,388,000USD | -7,733,000USD | -3,960,000USD | -4,308,000USD |
| Investments | 34,250,000USD | 24,302,000USD | 29,246,000USD | 9,409,000USD | -112,624,000USD | -11,895,000USD | -5,000USD | -93,000USD |
| Total Cashflows From Investing Activities | 34,250,000USD | 24,302,000USD | 29,246,000USD | 9,409,000USD | -112,624,000USD | -11,895,000USD | -5,000USD | -93,000USD |
| Total Cash From Financing Activities | 4,000USD | -2,113,000USD | 2,558,000USD | -71,000USD | 88,875,000USD | -1,014,000USD | 64,000USD | 82,941,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 0USD | 0USD | 91,075,000USD | 163,000USD | 169,000USD | 85,000,000USD |
| Change In Cash | 15,385,000USD | 7,766,000USD | 13,287,000USD | -506,000USD | -35,137,000USD | -20,636,000USD | -3,896,000USD | 78,633,000USD |
| Begin Period Cash Flow | 47,051,000USD | 39,285,000USD | 25,998,000USD | 26,504,000USD | 61,641,000USD | 82,277,000USD | 86,173,000USD | 7,540,000USD |
| End Period Cash Flow | 62,436,000USD | 47,051,000USD | 39,285,000USD | 25,998,000USD | 26,504,000USD | 61,641,000USD | 82,277,000USD | 86,173,000USD |
| Other Cashflows From Financing Activities | 4,000USD | — | 171,000USD | -71,000USD | -2,200,000USD | -1,177,000USD | 64,000USD | 82,941,000USD |
| Unclassified Operating Cash Flow | — | -1,581,000USD | -1,500,001USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | -2,113,000USD | 2,387,000USD | — | — | — | — | -85,000,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | -11,889,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | 11,895,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Net Income | -57,591,000USD | -20,588,000USD | -7,208,000USD | -13,564,000USD |
| Depreciation | -1,306,000USD | 16,000USD | 97,000USD | 110,000USD |
| Stock Based Compensation | 3,948,000USD | 439,000USD | 313,000USD | 412,000USD |
| Other Non Cash Items | 421,000USD | 473,000USD | 1,055,000USD | 3,810,000USD |
| Change In Working Capital | 356,000USD | 1,573,000USD | -81,000USD | -1,311,000USD |
| Total Cash From Operating Activities | -54,172,000USD | -18,087,000USD | -5,824,000USD | -10,543,000USD |
| Capital Expenditures | -95,000USD | -109,000USD | 0USD | 0USD |
| Free Cash Flow | -54,267,000USD | -18,196,000USD | -5,824,000USD | -10,543,000USD |
| Investments | -49,572,000USD | -11,998,000USD | 0USD | -1,000,000USD |
| Total Cashflows From Investing Activities | -49,667,000USD | -11,998,000USD | — | -1,000,000USD |
| Total Cash From Financing Activities | 89,249,000USD | 81,991,000USD | 0USD | 225,000USD |
| Sale Purchase Of Stock | 195,000USD | — | — | — |
| Issuance Of Capital Stock | 91,075,000USD | 85,332,000USD | 0USD | 225,000USD |
| Change In Cash | -14,590,000USD | 51,906,000USD | -5,824,000USD | -11,318,000USD |
| Begin Period Cash Flow | 61,641,000USD | 9,735,000USD | 15,559,000USD | 26,877,000USD |
| End Period Cash Flow | 47,051,000USD | 61,641,000USD | 9,735,000USD | 15,559,000USD |
| Other Cashflows From Financing Activities | 89,249,000USD | 81,659,000USD | — | 1,000,000USD |
| Unclassified Financing Cash Flow | — | -85,000,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | -1,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.